Therapeutic Targeting of CD95 and the TRAIL Death Receptors

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 294-310

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer

By                    

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 645-654

Spandidos Publications

Access to resources Recommend Favorite

Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system

By Okazaki Toshihiko   Sakamuro Daitoku  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 9, 2007-09 ,pp. : 581-588

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of X-rays and Neutrons on Lymphocyte Death and Transformation

By Hedges M.J.   Hornsey Shirley  

International Journal of Radiation Biology, Vol. 33, Iss. 3, 1978-03 ,pp. : 291-300

Informa Healthcare

Access to resources Recommend Favorite

Metallothionein and Fas (CD95) are Expressed in Squamous Cell Carcinoma of the Tongue

By Sundelin K.   Jadner M.   Norberg-Spaak L.   Davidsson A.   Hellquist H.B.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1860-1864

Elsevier

Access to resources Recommend Favorite